The Src/ABL kinase inhibitor dasatinib
(BMS-354825) inhibits function of normal human T-lymphocytes in vitro
The Src/ABL kinase inhibitor dasatinib
(BMS-354825) inhibits function of normal human T-lymphocytes in vitro
No Thumbnail Available
Date
2008
Authors
Blake, Stephen
Hughes, Timothy P
Mayrhofer, Graham
Lyons, Alan Bruce
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
Blake, S., Hughes, T.P., Mayrhofer, G.,
& Lyons, A.B., 2008. The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits
function of normal human T-lymphocytes in vitro. CLINICAL IMMUNOLOGY, 127(3),
330-339.